MBZUAI researchers led by Dr. Mohammad Yaqub are developing AI algorithms for real-time medical diagnoses, including tools for multiple sclerosis and congenital heart disease. The team developed ScanNav, an AI fetal anomaly assessment system licensed by GE Healthcare for Voluson SWIFT ultrasound machines. ScanNav assists doctors during anomaly scans after 20 weeks of gestation to check for conditions like heart issues and spina bifida. Why it matters: This research has the potential to significantly improve the speed and accuracy of medical diagnoses in the UAE and beyond, addressing critical gaps in healthcare.
MBZUAI is developing AI algorithms to intelligently process data from wearables and home sensors for remote patient monitoring. The algorithms aim to analyze multiple strands of health data to provide a more comprehensive view of a patient's health, distinguishing between genuine emergencies and benign situations. MBZUAI's provost, Professor Fakhri Karray, believes this approach could handle 20-25% of diagnoses virtually, reducing the burden on healthcare systems. Why it matters: This research could significantly improve healthcare efficiency and accessibility in the UAE and beyond by enabling more effective remote patient monitoring and reducing unnecessary hospital visits.
A KAUST Rapid Research Response Team (R3T) is collaborating with healthcare stakeholders to combat COVID-19. Xin Gao and his Structural and Functional Bioinformatics (SFB) Group are developing an AI-based diagnosis pipeline from CT scans of COVID-19 patients. The AI pipeline aims to address the high false negative rates associated with nucleic acid detection. Why it matters: This research could improve COVID-19 diagnostics and potentially inform understanding of viral pathogenesis.
MBZUAI doctoral student Mai A. Shaaban and colleagues developed MedPromptX, a system that analyzes chest X-rays and patient data to aid lung disease diagnoses. MedPromptX uses multimodal large language models with visual grounding and few-shot prompting, trained on a new dataset of 6,000 patient records (MedPromptX-VQA) derived from MIMIC-IV and MIMIC-CXR. The system addresses the challenge of incomplete electronic health records by leveraging the knowledge embedded in large language models to interpret lab results. Why it matters: This research advances AI-driven medical diagnostics by integrating diverse data sources and addressing data gaps, potentially leading to quicker and more accurate diagnoses.
MBZUAI and Sheikh Shakbout Medical City researchers developed PECon, a deep learning method for pulmonary embolism detection using CT scans and electronic health records. PECon uses neural networks and contrastive learning to encode and align image and text data. The method aims to improve diagnosis accuracy and speed, potentially saving lives. Why it matters: This research demonstrates AI's potential to enhance medical diagnostics in the UAE, addressing a critical healthcare challenge.
A KAUST team led by Xin Gao developed an AI model for COVID-19 detection from CT scans, addressing limitations of existing methods. The model incorporates a novel embedding strategy, a CT scan simulator, and a 2.5D deep-learning algorithm. Tested at King Faisal Specialist Hospital, the model demonstrated high accuracy in detecting COVID-19 cases. Why it matters: This research provides a valuable tool for rapid and accurate COVID-19 diagnosis in the region, especially in early-stage infections, improving healthcare outcomes.
A senior lecturer at the University of New South Wales discussed the use of AI to improve early prognosis and personalized treatment plans for neurodegenerative diseases, cardiovascular imaging and multiomics. The lecture highlighted the potential of AI algorithms to detect subtle changes at early stages through advanced multiomics techniques and medical imaging analysis. The speaker has expertise in analyzing medical images and has collaborated with medical professionals to develop AI tools for diagnosis of cancer, neurodegenerative disease, and heart disease. Why it matters: AI-driven prognosis and treatment planning promises earlier intervention and improved outcomes for challenging diseases in the region.
MBZUAI researchers developed MedAgentSim, a simulated hospital environment to evaluate AI diagnostic abilities. The simulation uses LLM-powered agents to mimic doctor-patient conversations, providing a dynamic assessment of diagnostic skills. The system includes doctor, patient, and evaluator agents that interact within the simulated hospital, making real-time decisions. Why it matters: This research offers a more realistic evaluation of AI in clinical settings, addressing limitations of current benchmarks and potentially improving AI's use in healthcare.